Home Clinical Research Current Clinical Trails A Randomized Open-Label Phase 3 Study of XL092 +Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer

XL092-303

A Randomized Open-Label Phase 3 Study of XL092 +Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer

Condition: Metastatic Colorectal Cancer-Adenocarcinoma of the colon or rectum | Last Updated: 3 Jun 22 | Status:

View Full Study